论文部分内容阅读
目的观察脑安胶囊对高血压脑血管功能异常的效果。方法将82例符合纳入标准的高血压脑血管功能异常患者,随机分为两组,治疗组42例,对照组40例。对照组给予健康管理和一般干预治疗,治疗组在对照组的基础上口服脑安胶囊。观察干预3个月后两组脑血管功能评分及血压的变化。结果两组经治疗后,脑血管功能评分均有显著改善,治疗组优于对照组,差异有统计学意义(P<0.05);两组治疗后收缩压和舒张压均有下降,两组降压效果相比较,差异无统计学意义(P>0.05)。结论:脑安胶囊可改善高血压脑血管功能异常患者的脑血管血液动力学及血管功能。
Objective To observe the effect of Na Ann capsule on hypertensive cerebrovascular dysfunction. Methods Eighty-two patients with hypertensive cerebrovascular dysfunction who met the inclusion criteria were randomly divided into two groups: treatment group (42 cases) and control group (40 cases). The control group was given health management and general intervention treatment. The treatment group was given Oral Capsule on the basis of the control group. The changes of cerebrovascular function score and blood pressure were observed in 3 months after intervention. Results After treatment, the scores of cerebrovascular function in both groups were significantly improved, the treatment group was superior to the control group, the difference was statistically significant (P <0.05); systolic and diastolic blood pressure decreased after treatment in both groups Compared with the pressure effect, the difference was not statistically significant (P> 0.05). Conclusion: Na’an Capsule can improve cerebrovascular hemodynamics and vascular function in patients with hypertensive cerebrovascular dysfunction.